Takeda's Pipeline Cleanup Leads to Layoffs and Program Cuts.

TL;DR
Takeda is ending its seven-year partnership with Theravance and cutting a partnered Crohn's program after a Phase IIb failure. The company is also cutting seven clinical trials for various diseases and cancers and plans to lay off over 180 workers.
Want the full story? Read the original reporting
Read on Endpoints News